EMEA-001136-PIP02-19

Key facts

Invented name
Doptelet
Active substance
avatrombopag maleate
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0096/2020
PIP number
EMEA-001136-PIP02-19
Pharmaceutical form(s)
  • Film-coated tablet
  • Powder for oral suspension
Condition(s) / indication(s)
Treatment of chemotherapy-induced thrombocytopenia
Route(s) of administration
Oral use
Contact for public enquiries
Dova Pharmaceuticals Ireland Limited

Tel. +1 9197485975
E-mail: clinical@dova.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating